Rolf T Urbanus Selected Research

Stroke (Strokes)

1/2022	Flow Cytometry Based Platelet Reactivity Testing to Predict the Occurrence of Per-operative Solid Microemboli During Carotid Endarterectomy.
10/2016	Antiphospholipid Antibodies and the Risk of Stroke in Urban and Rural Tanzania: A Community-Based Case-Control Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rolf T Urbanus Research Topics

Disease

29	Thrombosis (Thrombus) 03/2024 - 12/2004
21	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 12/2023 - 12/2004
11	Hemorrhage 01/2023 - 02/2016
6	Thrombocytopenia (Thrombopenia) 01/2022 - 01/2016
6	Inflammation (Inflammations) 01/2020 - 01/2009
6	Infections 01/2020 - 07/2014
4	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2023 - 07/2013
4	Autoimmune Diseases (Autoimmune Disease) 09/2015 - 02/2005
3	Sepsis (Septicemia) 01/2018 - 06/2011
2	Heart Failure 02/2023 - 01/2023
2	Blood Platelet Disorders (Thrombocytopathy) 02/2023 - 01/2020
2	Hemophilia A (Haemophilia) 01/2023 - 05/2022
2	Body Weight (Weight, Body) 01/2023 - 05/2022
2	Stroke (Strokes) 01/2022 - 10/2016
2	Thrombasthenia (Glanzmann Thrombasthenia) 09/2021 - 10/2020
2	Venous Thrombosis (Deep-Vein Thrombosis) 09/2021 - 11/2016
2	Neoplasms (Cancer) 09/2021 - 01/2017
2	Communicable Diseases (Infectious Diseases) 10/2016 - 07/2012
2	Myocardial Infarction 11/2009 - 10/2009
1	Thrombophilia 01/2023
1	Activated Protein C Resistance (APC Resistance) 01/2023
1	COVID-19 08/2022
1	Critical Illness (Critically Ill) 08/2022
1	Thrombotic Thrombocytopenic Purpura 01/2022
1	Purpura 12/2021
1	HELLP Syndrome 12/2021
1	Hemolysis 12/2021
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2021
1	Thromboembolism 09/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2021
1	HIV Infections (HIV Infection) 01/2021
1	Bernard-Soulier Syndrome (Giant Platelet Syndrome) 10/2020
1	Myocardial Ischemia (Ischemic Heart Diseases) 07/2020
1	Chest Pain (Chest Pains) 07/2020
1	Schistosomiasis mansoni 01/2020
1	Malaria 01/2020
1	Vascular Diseases (Vascular Disease) 12/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2019
1	Pre-Eclampsia (Preeclampsia) 12/2019
1	Dengue (Dengue Fever) 01/2019
1	Hypoxia (Hypoxemia) 01/2019

Drug/Important Bio-Agent (IBA)

15	Antiphospholipid AntibodiesIBA 12/2023 - 12/2004
10	AntibodiesIBA 01/2023 - 12/2004
9	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 08/2022 - 12/2004
6	AnticoagulantsIBA 01/2023 - 03/2008
5	von Willebrand FactorIBA 01/2022 - 11/2015
5	AutoantibodiesIBA 09/2015 - 11/2005
5	beta 2-Glycoprotein I (Apolipoprotein H)IBA 08/2010 - 12/2004
4	Thrombin FDA Link 01/2019 - 10/2009
4	P-SelectinIBA 01/2018 - 01/2016
4	Glycoproteins (Glycoprotein)IBA 07/2014 - 01/2011
3	EpitopesIBA 03/2024 - 02/2005
3	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2023 - 02/2016
3	Inosine Triphosphate (ITP)IBA 01/2023 - 01/2021
3	Fibrinogen (Factor I)FDA Link 01/2022 - 09/2017
3	Heparin (Liquaemin)FDA LinkGeneric 12/2021 - 11/2016
3	Biomarkers (Surrogate Marker)IBA 07/2020 - 12/2011
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 12/2011
3	Phospholipids (Phosphatides)FDA LinkGeneric 05/2019 - 07/2012
3	Immunoglobulin G (IgG)IBA 10/2016 - 02/2005
2	emicizumabIBA 01/2023 - 05/2022
2	Vitamin K FDA Link 01/2023 - 01/2023
2	Thrombopoietin ReceptorsIBA 01/2023 - 01/2021
2	Blood Coagulation Factors (Coagulation Factor)IBA 01/2023 - 01/2018
2	Protein CIBA 01/2023 - 01/2009
2	Hemostatics (Antihemorrhagics)IBA 06/2022 - 01/2021
2	thiamine triphosphorate (TTP)IBA 01/2022 - 12/2021
2	Adenosine Diphosphate (ADP)IBA 10/2020 - 09/2017
2	AntigensIBA 01/2019 - 10/2009
2	RivaroxabanIBA 11/2016 - 01/2016
2	low density lipoprotein receptor-related protein 8IBA 03/2016 - 01/2011
1	Prothrombin (Factor II)IBA 01/2023
1	eltrombopag FDA Link 01/2023
1	C-Reactive ProteinIBA 08/2022
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2022
1	APTIBA 01/2022
1	caplacizumabIBA 01/2022
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2022
1	EnzymesIBA 12/2021
1	COVID-19 VaccinesIBA 12/2021
1	IntegrinsIBA 09/2021
1	Thromboxane A2 (A2, Thromboxane)IBA 10/2020
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2020
1	TinIBA 01/2020
1	CytokinesIBA 01/2020
1	Kallikreins (Kallikrein)IBA 01/2020
1	Monatide (IMS 3015)IBA 01/2020
1	LipidsIBA 01/2020
1	SerpinsIBA 01/2020
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 01/2020
1	ProteomeIBA 01/2020
1	1- acetyl- 1,2,3,3a,8,8a- hexahydro- 8a- hydroxy- 5- methoxypyrrolo(2,3- b)indole (CHMI)IBA 01/2020
1	Quinacrine (Mepacrine)IBA 01/2020
1	VaccinesIBA 01/2020
1	RNA (Ribonucleic Acid)IBA 12/2019
1	ORALIT (ORS)IBA 05/2019
1	EndotoxinsIBA 01/2019

Therapy/Procedure

9	Therapeutics 02/2023 - 02/2016
3	Heart-Assist Devices 02/2023 - 09/2021
1	Surgical Instruments (Clip) 01/2022